Current capabilities and limitations for the diagnosis of etiology of ocular tuberculosis: a review

Authors

  • Viktoriia Kolesnichenko Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine image/svg+xml
  • Oleksandra Dorokhova Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine image/svg+xml https://orcid.org/0000-0002-7255-012X
  • Oleksandra Zborovska Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine image/svg+xml

DOI:

https://doi.org/10.31288/Ukr.j.ophthalmol.202656976

Keywords:

ocular tuberculosis, uveitis, Mycobacterium tuberculosis, PCR, interferon-gamma release assays, tuberculin test

Abstract

Ocular tuberculosis (OTB) remains one of the most diagnostically challenging extrapulmonary forms of tuberculosis in terms of determining the etiology. The paucibacillary nature of the disease, small quantity of intraocular samples, and pathogenetic heterogeneity significantly complicate the direct confirmation of Mycobacterium tuberculosis (MBT) in ocular tissue and fluid samples. This paper reviewed current capabilities and limitations for the diagnosis of etiology of OTB. Molecular gene methods for direct detection of MBT, including polymerase chain reaction (PCR), automated molecular platforms and studies on cell-free DNA analysis, were considered. Despite advances in these methods, they still do not have enough sensitivity for negative results to rule out OTB. Special attention was given to the methods allowing indirect confirmation of MBT infection, tuberculin skin test (TST) and interferon-gamma release analysis (IGRA), particularly, QuantiFERON. A positive IGRA result indicates the presence of a specific immune response to MBT, but does not localize the infectious process or independently confirm a causal relationship between MBT infection and intraocular inflammation. The absence of an independent and sufficiently sensitive reference standard for OTB detection is a major issue in the assessment of diagnostic accuracy of current OTB detection methods. Future research should be aimed not only at increasing the sensitivity of direct diagnostic methods, but also focused on the search for, and independent validation of  markers that will allow differentiation between etiologically MBT-related intraocular inflammation from concomitant latent infection.

References

Ludi Z, Sule AA, Samy RP, et al. Diagnosis and biomarkers for ocular tuberculosis: From the present into the future. Theranostics. 2023;13(7):2088-2113. https://doi.org/10.7150/thno.81488

Konana VK, Babu K. Current concepts in the diagnosis of ocular tuberculosis: A narrative review. Taiwan J Ophthalmol. 2025;15(2):203-211. https://doi.org/10.4103/tjo.TJO-D-24-00115

Alabed ST, Finkel D. Ocular TB as the only manifestation of TB: diagnostic uncertainty and treatment thresholds. Int Ophthalmol. 2026;46(1):268. https://doi.org/10.1007/s10792-026-04134-3

Tungsattayathitthan U, Boonsopon S, Tesavibul N, et al. Interferon-gamma release assays in tuberculous uveitis: a comprehensive review. Int J Ophthalmol. 2022;15(9):1520-1528. https://doi.org/10.18240/ijo.2022.09.16

Putera I, Ten Berge JCEM, Thiadens AAHJ, et al. Clinical Features and Predictors of Treatment Outcome in Patients with Ocular Tuberculosis from the Netherlands and Indonesia: The OculaR TB in Low versus High Endemic Countries (ORTEC) Study. Ocul Immunol Inflamm. 2025;33(1):86-97.https://doi.org/10.1080/09273948.2024.2359614

Basu S, Elkington P, Rao NA. Pathogenesis of ocular tuberculosis: New observations and future directions. Tuberculosis (Edinb). 2020;124:101961. https://doi.org/10.1016/j.tube.2020.101961

Agrawal R, Testi I, Rousselot A, et al. Insights into the molecular pathogenesis of ocular tuberculosis. Tuberculosis (Edinb). 2021;126:102018. https://doi.org/10.1016/j.tube.2020.102018

Putera I, Widodo E, Riasanti M, et al. Ocular tuberculosis with Mycobacterium tuberculosis DNA presence in ocular fluid: will post-COVID era bring a difference? Eye (Lond). 2024;38(15):3027-3029.https://doi.org/10.1038/s41433-024-03200-3

Balne PK, Modi RR, Choudhury N, et al. Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis. J Ophthalmic Inflamm Infect. 2014;4(1):10.https://doi.org/10.1186/1869-5760-4-10

Barik MR, Rath S, Modi R, et al. Normalised quantitative polymerase chain reaction for diagnosis of tuberculosis-associated uveitis. Tuberculosis (Edinb). 2018;110:30-35. https://doi.org/10.1016/j.tube.2018.03.005

Sharma K, Sharma M, Ayyadurai N, et al. Comparative Evaluation of GeneXpert MTB/RIF Ultra and GeneXpert MTB/RIF for Detecting Tuberculosis and Identifying Rifampicin Resistance in Pars Plana Vitrectomy Samples of Patients with Ocular Tuberculosis. Ocul Immunol Inflamm. 2023;31(5):914-920. https://doi.org/10.1080/09273948.2022.2064880

Sharma K, Sharma M, Ayyadurai N, et al. Evaluating Truenat Assay for the Diagnosis of Ocular Tuberculosis and Detection of Drug Resistance. Ocul Immunol Inflamm. 2024;32(6):976-982. https://doi.org/10.1080/09273948.2023.2170888

Sharma K, Sharma M, Joshi H, et al. Evaluation of Mycobacterium Tuberculosis Derived Cell-Free DNA-Based Multi-Targeted Real-Time PCR from Vitreous Fluid (VF) Samples to Diagnose Ocular Tuberculosis. Ocul Immunol Inflamm. 2025;33(9):1907-1912. https://doi.org/10.1080/09273948.2025.2532820

Agarwal A, Agrawal R, Gunasekaran DV, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends. Ocul Immunol Inflamm. 2019;27(3):465-473. https://doi.org/10.1080/09273948.2017.1406529

La Distia Nora R, Putera I, Khalisha DF, et al. The diagnostic value of polymerase chain reaction for ocular tuberculosis diagnosis in relation to antitubercular therapy response: a meta-analysis. Int J Infect Dis. 2021;110:394-402. https://doi.org/10.1016/j.ijid.2021.07.075

Fernández-Zamora Y, Finamor LP, Silva LMP, et al. Role of Interferon-Gamma Release Assay for the Diagnosis and Clinical Follow up in Ocular Tuberculosis. Ocul Immunol Inflamm. 2023;31(2):304-311.https://doi.org/10.1080/09273948.2022.2027459

Ang M, Wong WL, Li X, et al. Interferon γ release assay for the diagnosis of uveitis associated with tuberculosis: a Bayesian evaluation in the absence of a gold standard. Br J Ophthalmol. 2013;97(8):1062-1067.https://doi.org/10.1136/bjophthalmol-2012-302199

Xia J, Palestine AG, Reddy AK. Diagnostic Utility of QuantiFERON-Gold Testing in Patients with Ocular Inflammation in a Low-Endemic Tuberculosis Region. Am J Ophthalmol. 2024;264:1-7.https://doi.org/10.1016/j.ajo.2024.03.010

Putera I, Rothova A, La Distia Nora R. Comparison of uveitis manifestations in patients with active systemic tuberculosis and those with positive interferon-gamma release assay without active disease. Eye (Lond). 2025;39(9):1772-1780. https://doi.org/10.1038/s41433-025-03751-z

La Distia Nora R, Putera I, Riasanti M, et al. Antitubercular therapy for uveitis of undetermined cause with positive interferon-gamma release assay: a single-blind, single-centre, phase 2 randomised controlled trial. EClinicalMedicine. 2025;88:103511. https://doi.org/10.1016/j.eclinm.2025.103511

Published

2026-10-30

Most read articles by the same author(s)